Vitiligo spreads when something triggers your immune system to attack the pigment-producing cells in your skin. The most common culprits are skin injuries, chemical exposures, emotional stress, sunburn, and nutrient deficiencies. Understanding these triggers can help you slow the progression of existing patches and reduce the chances of new ones appearing.
Skin Injuries and the Koebner Phenomenon
One of the most well-documented triggers for new vitiligo patches is physical trauma to the skin, a process called the Koebner phenomenon. When your skin is injured, whether from a cut, scrape, burn, or even repeated friction, new depigmented patches can form at the exact site of the injury. Vitiligo is considered one of the conditions where this response is most reliably observed.
The triggers don’t have to be dramatic. Mechanical stress from tight clothing, belt lines, or watch bands can be enough. Surgical incisions, tattoos, and even aggressive skin treatments like chemical peels or dermabrasion have all been linked to new patch formation in people with vitiligo. Sunburns are particularly problematic because they combine physical damage with a flood of free radicals and hydrogen peroxide in the skin, which in predisposed individuals activates an immune response that targets melanocytes.
Chemical Exposures in Everyday Products
Certain chemicals can directly destroy melanocytes and trigger or worsen vitiligo. These chemicals are structurally similar to tyrosine, an amino acid your body uses to produce melanin. When they enter the skin, they disrupt pigment production and can set off an autoimmune attack on melanocytes. This connection has been recognized for over 75 years, first as an occupational hazard and later in common consumer products.
The most frequently implicated household product is hair dye, accounting for 27% of cases in one study. The culprit is typically a compound called para-phenylenediamine (PPD). Beyond hair dye, phenol-based chemicals show up in a surprising range of everyday items: disinfectants, detergents, cosmetics, adhesives, diaper creams, and pharmaceutical products. In 2013, a skin-lightening cream containing rhododendrol caused vitiligo in over 16,000 users in Japan, illustrating how widespread the risk can be from a single product.
Occupational exposures carry risk too. Factory workers handling lubricating oils containing certain phenol compounds have developed depigmentation on their hands and arms. Hospital workers using germicidal detergents containing 4-tert-amylphenol have experienced the same. If you notice new patches appearing on areas that frequently contact cleaning products, adhesives, or industrial chemicals, the exposure itself may be driving the spread.
How Oxidative Stress Damages Melanocytes
At the cellular level, the most widely accepted explanation for vitiligo progression involves oxidative stress. Your melanocytes are under constant low-level assault from reactive oxygen species (ROS), which are unstable molecules that damage DNA, proteins, and cell membranes. In healthy skin, antioxidant defenses keep these molecules in check. In vitiligo, that balance breaks down.
When ROS levels overwhelm your skin’s defenses, the damage cascades. Mitochondria, the energy-producing structures inside melanocytes, start to malfunction. Proteins misfold. The cell’s internal recycling systems eventually shut down under persistent stress. The damaged melanocytes then release fragments that your immune system recognizes as foreign, triggering the autoimmune attack that kills pigment cells and creates visible white patches. Anything that increases oxidative stress in your skin, from sunburn to chemical exposure to chronic inflammation, feeds this cycle.
Psychological Stress and Immune Activation
Emotional stress is one of the most commonly reported triggers for vitiligo flares, and the mechanism is more than just anecdotal. When your body is under psychological stress, cells release a protein called inducible HSP70. This stress protein, once outside the cell, activates immune cells called dendritic cells and helps them present melanocyte proteins to killer T cells. The result is a targeted immune attack on your pigment-producing cells.
This creates a difficult feedback loop. Vitiligo itself causes significant psychological distress, which generates more stress proteins, which can drive further depigmentation. While eliminating stress entirely isn’t realistic, it’s worth recognizing that major life stressors, prolonged anxiety, and emotional upheaval are genuine biological triggers for disease activity, not just a vague “stress makes everything worse” platitude.
Thyroid Disease and Autoimmune Connections
Vitiligo rarely exists in isolation. It’s an autoimmune condition, and having one autoimmune disease raises your risk of developing others. The strongest association is with thyroid disorders, which are about three times more common in people with vitiligo than in the general population. Hashimoto’s thyroiditis and hyperthyroidism are particularly relevant because elevated levels of anti-thyroid antibodies are frequently associated with increased vitiligo activity.
Other conditions linked to vitiligo include connective tissue diseases (about 1.8 times more common) and inflammatory skin conditions (about 2.2 times more common). These overlapping autoimmune processes don’t just coexist. They can amplify each other. Heightened inflammatory and autoimmune activity from a concurrent condition often correlates with a more severe or active course of vitiligo. If your patches are spreading and you haven’t had your thyroid checked recently, it’s worth investigating.
Vitamin D Deficiency
People with vitiligo tend to have significantly lower vitamin D levels than those without the condition. In one case-control study, vitiligo patients averaged 25.1 ng/mL of serum vitamin D compared to 37.9 ng/mL in healthy controls. Forty percent of vitiligo patients were fully deficient, compared to 25% of controls.
This isn’t just a coincidence of avoiding sun exposure on depigmented skin. The research shows a statistically significant inverse correlation between vitamin D levels and disease severity: people with more extensive vitiligo typically have lower vitamin D. Because vitamin D plays a major role in regulating the immune system, deficiency may worsen the autoimmune processes driving the disease. This creates a catch-22 for vitiligo patients, who often limit sun exposure to protect depigmented skin, potentially lowering their vitamin D levels further. Supplementation or careful, protected sun exposure may help break that cycle.
Hormonal Changes During Pregnancy
Hormonal shifts can influence vitiligo activity in both directions. During pregnancy, elevated levels of cortisol, estrogen, progesterone, and the anti-inflammatory molecule IL-10 appear to exert a protective effect against melanocyte destruction. Many women experience improvement or stabilization of their vitiligo while pregnant.
The postpartum period is a different story. After delivery, the loss of pregnancy’s natural immunosuppressive state can trigger a rebound in autoimmune activity. The rapid hormonal drop, combined with sleep deprivation and the stress of new parenthood, creates conditions ripe for a vitiligo flare. Other hormonal transitions, particularly those involving thyroid function, can similarly destabilize the disease.
Active Versus Stable Disease
Not all vitiligo behaves the same way. In clinical studies, the majority of patients with non-segmental vitiligo have active disease at any given time. In one study of 79 patients, 64 had actively spreading patches while only 15 had been stable for more than six months. Even among those tracked over a full year, more than half continued to show active progression.
This means that for most people with vitiligo, the disease is not naturally inclined to stay put. Active management of the triggers described above, minimizing skin trauma, avoiding phenol-containing products, managing stress, maintaining adequate vitamin D, and monitoring thyroid function, represents the most practical approach to slowing the spread. Recognizing whether your vitiligo is currently active or stable also matters for treatment decisions, since some therapies work best during specific disease phases.